Citrus · End-to-End Remote Site Monitoring and Clinical Trial Management Solution

Clinical trial costs have been constantly on the rise in the last years the total cost of a single big trial can reach €600 million. The increasing costs have significant implications for public health, as it affects pharmaceutical and biotech companies’ willingness to undertake clinical trials, which in turn limits patient access to novel treatments. To monitor clinical trials, it is a common practice to conduct site visits frequently and to verify source data during these visits. On-Site monitoring accounts for up to 14% of overall clinical study costs.These costs can be reduced by making wider use of mobile technologies, centrally available data to evaluate site performance, electronic data capture, and other efficiency-improving options.Existing systems on the market do not offer solutions to the problem. There are systems for clinical trial financial management; systems for electronic data capture; systems that provide access to electronic health records (EHR) and lab results (e-source) or access to mobile health devices. All these separate systems do not necessarily talk to each other, staff at clinical research sites report usage of three different systems to enter patient/study data.Citrus - Clinical Trial Management & Remote Monitoring is the first revolutionary solution to offer remote monitoring capabilities. It is an end-to-end solution which includes CTMS, direct access to lab results and EHR, access to mHealth devices and it ensures data privacy compliance when data is accessed remotely.Founded in 2008, CRU Hungary leads the clinical research services in Center-East Europe. Their 4 clinical research sites are preferred companies such as Pfizer, AstraZeneca and GSK. Our IT department have been developing solutions that answer to real pains in the clinical trial process and whose purchase is currently negotiated with T-Mobile and leading university hospitals in Hungary. We expect a 5-year ROI of 9.49.